NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024

次世代シーケンシング(NGS)サンプル調製の世界市場予測(~2024年)

◆タイトル:NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024
◆商品コード:BT 7081
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年5月7日
◆ページ数:204
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

NGSサンプル調製の世界市場は、2019年の11億米ドルから2024年には27億米ドルに達し、この期間中18.7%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、診断およびゲノミクス研究におけるNGSの利用の増加、診断へのNGSの採用の増加(NGS製品およびサービスのコストの低下による)、およびシーケンシング技術開発の低コスト化が考えられます。当調査レポートでは、次世代シーケンシング(NGS)サンプル調製の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品(試薬、ワークステーション)別分析、ワークフロー(ライブラリ作製、ターゲットエンリッチメント)別分析、用途(感染症、がん診断)別分析、技術(SMRT、ナノポア)別分析、次世代シーケンシング(NGS)サンプル調製の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The NGS sample preparation market to register a CAGR of 18.7% from 2019 to 2024.”
The NGS sample preparation market is projected to reach USD 2.7 billion by 2024 from USD 1.1 billion in 2019, at a CAGR of 18.7% during the forecast period. The growth of this market is driven by increasing application of NGS in diagnostics and genomics research, increasing adoption of NGS for diagnostics (due to the decreasing cost of NGS products and services), and development of low-cost sequencing technologies are expected to drive the market growth in the future.

“The library preparation products segment to register the highest CAGR in the NGS reagents and consumables market.”

Based on workflow, the reagents & consumables segment is subsegmented into library preparation, target enrichment, and quality control. Library preparation segment is classified into DNA (Human WGS, targeted sequencing, whole exome sequencing, and others) and RNA (gene expression analysis, whole transcriptome, and others) on the basis of type. In 2018, the library preparation segment accounted for the largest share of the NGS reagents and consumables market. Advancements in the NGS protocols for library preparation and the increasing number of research activities are driving the growth of the library preparation market.

“The academic institutes & research centers segment is expected to dominate the end-user segment.”
Based on end user, the NGS sample preparation market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The academic institutes & research centers segment is expected to account for the largest share the NGS sample preparation market during the forecast period. The increasing number of collaborations between NGS market players and academic & research institutions; availability of financial support for genomics R&D across regions; and the development of cost-effective NGS products and services for researchers are the major factors supporting the growth of this end-user segment.

“The NGS sample preparation market in the APAC is projected to grow at the highest rate during the forecast period.”
The Asia Pacific NGS sample preparation market is expected to witness the highest CAGR from 2019 to 2024. Increasing financial support from public as well as private agencies, increasing number of NGS-based research projects, increasing awareness about precision medicine, and high incidence of chronic diseases in key APAC countries are the major factors driving the growth of this regional market.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 – 31% , Tier 2 – 49%, and Tier 3 – 20%
• By Designation: C-level – 28%, Director-level – 19%, and Others – 53%
• By Region: North America – 33%, Europe – 31%, APAC – 19%, and RoW – 17%

Several companies such as Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), and Beckman Coulter (a subsidiary of Danaher), among others, are investing in high-growth markets to gain significant profits and increase their share in the NGS sample preparation market.

Research Coverage
This report studies the NGS sample preparation market based on product, end user, application, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on NGS sample preparation offered by the top 15 players in the market. The report analyzes the NGS sample preparation market by product, application, end user, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for NGS sample preparation across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the NGS sample preparation market.

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and recent developments of the leading players in the NGS sample preparation market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Breakdown of primaries 25
2.1.2.2 Key data from primary sources 26
2.2 MARKET SIZE ESTIMATION 26
2.2.1 PRODUCT-BASED MARKET ESTIMATION 27
2.2.2 END USER-BASED MARKET ESTIMATION 27
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 ASSUMPTIONS FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36
4.1 NGS SAMPLE PREPARATION: MARKET OVERVIEW 36
4.2 NGS SAMPLE PREPARATION MARKET SHARE, BY PRODUCT, 2018 37
4.3 NGS SAMPLE PREPARATION MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 38
4.4 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 39
4.5 NGS SAMPLE PREPARATION MARKET, BY REGION 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Advancements in NGS platforms 42
5.2.1.2 Declining cost of sequencing 42
5.2.1.3 Improving reimbursement scenario for NGS-based diagnostic tests 43
5.2.2 RESTRAINTS 44
5.2.2.1 End user budget constraints in developing countries 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Initiatives and funding from government & private bodies for large-scale sequencing projects 44
5.2.3.2 Increasing applications of NGS 45
5.2.4 CHALLENGES 45
5.2.4.1 Ethical issues 45
6 NGS SAMPLE PREPARATION MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 REAGENTS & CONSUMABLES 47
6.2.1 RISING ADOPTION OF NGS IS SUPPORTING THE USE OF NGS REAGENTS AND CONSUMABLES 47
6.3 NGS WORKSTATIONS 49
6.3.1 HIGH THROUGHPUT AND REDUCTION IN HANDS-ON TIME ENSURES THE ADOPTION OF WORKSTATIONS IN NGS WORKFLOW 49
7 NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW 50
7.1 INTRODUCTION 51
7.2 LIBRARY PREPARATION 51
7.2.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION 51
7.2.1.1 Availability of products from various players drives the market for this segment 51
7.2.2 DNA LIBRARY PREPARATION 53
7.2.2.1 Whole exome sequencing 54
7.2.2.1.1 WES is more cost-effective and produces smaller, more manageable datasets for faster analysis 54
7.2.2.2 Targeted sequencing 55
7.2.2.2.1 Targeted sequencing helps to investigate a variety of disease areas, such as oncology, inherited diseases, immunology, and infectious diseases 55
7.2.2.3 Whole genome sequencing 56
7.2.2.3.1 WGS enables clinicians to understand the genetic makeup of patients and supports the diagnosis of various diseases 56
7.2.2.4 Others 56
7.2.3 RNA LIBRARY PREPARATION 57
7.2.3.1 Gene expression analysis 58
7.2.3.1.1 Gene expression analysis is adopted on a large scale during immunology & stem cell research and neurobiology studies to evaluate cell differentiation and development 58
7.2.3.2 Whole transcriptome sequencing 59
7.2.3.2.1 Whole transcriptome sequencing helps in understanding the functional elements of the genome and underlying mechanisms of development and disease 59
7.2.3.3 Other RNA applications 60
7.3 TARGET ENRICHMENT 61
7.3.1 TARGETED SEQUENCING 62
7.3.1.1 Increased adoption of targeted sequencing in several diagnostics to drive market growth 62
7.3.2 WHOLE EXOME SEQUENCING 63
7.3.2.1 WES is increasingly being used in clinical diagnostics for a variety of indications to identify the underlying genetic cause of disease 63
7.3.3 OTHERS 63
7.4 QUALITY CONTROL 64
7.4.1 IMPORTANCE OF QUALITY CONTROL STEP IN THE NGS WORKFLOW & RISING NUMBER OF RESEARCH ACTIVITIES USING NGS TECHNOLOGY ARE THE KEY FACTORS DRIVING MARKET GROWTH 64
8 NGS LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY TECHNOLOGY 66
8.1 INTRODUCTION 67
8.2 SEQUENCING BY SYNTHESIS (SBS) 68
8.2.1 SBS HAS A WIDE CUSTOMER BASE OWING TO ITS WELL-ESTABLISHED PRECISION IN SEQUENCING AS WELL AS ITS BROAD APPLICATION BASE 68
8.3 ION SEMICONDUCTOR SEQUENCING 69
8.3.1 EXTENSIVE APPLICATIONS OF ION SEMICONDUCTOR SEQUENCING TO DRIVE MARKET GROWTH 69
8.4 SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 70
8.4.1 HIGH COST OF SMRT-BASED PLATFORMS TO RESTRAIN MARKET GROWTH 70
8.5 NANOPORE SEQUENCING 71
8.5.1 SMALL SIZE AND LOW EQUIPMENT COSTS TO SUPPORT THE ADOPTION OF NANOPORE SEQUENCING PLATFORMS BY VARIOUS END USERS 71
8.6 OTHER SEQUENCING TECHNOLOGIES 72
9 NGS SAMPLE PREPARATION MARKET, BY APPLICATION 73
9.1 INTRODUCTION 74
9.2 DIAGNOSTICS 74
9.2.1 CANCER DIAGNOSTICS 76
9.2.1.1 Increasing cancer patient population across the globe is driving this segment 76
9.2.2 INFECTIOUS DISEASE DIAGNOSTICS 77
9.2.2.1 Lack of awareness about NGS-based diagnosis for infectious diseases is limiting the growth of this market 77
9.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS 78
9.2.3.1 Increasing adoption of NIPT to drive market growth 78
9.2.4 OTHER DISEASE DIAGNOSTIC APPLICATIONS 78

9.3 DRUG DISCOVERY 79
9.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS FOR DRUG DISCOVERY AND DEVELOPMENT TO DRIVE THE ADOPTION NGS SAMPLE PREPARATION PRODUCTS 79
9.4 AGRICULTURAL & ANIMAL RESEARCH 80
9.4.1 FUNDING & SUPPORT FOR ANIMAL AND PLANT GENOMICS RESEARCH TO SUPPORT THE ADOPTION OF NGS SAMPLE PREPARATION PRODUCTS 80
9.5 OTHER APPLICATIONS 81
10 NGS SAMPLE PREPARATION MARKET, BY END USER 83
10.1 INTRODUCTION 84
10.2 ACADEMIC INSTITUTES & RESEARCH CENTERS 84
10.2.1 AVAILABILITY OF FINANCIAL SUPPORT FOR GENOMICS RESEARCH TO SUPPORT THE GROWTH OF THIS SEGMENT 84
10.3 HOSPITALS & CLINICS 86
10.3.1 NGS TECHNOLOGY TO WITNESS SIGNIFICANT ADOPTION IN DISEASE DIAGNOSIS OWING TO ITS ADVANTAGES OVER CONVENTIONAL METHODS 86
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 86
10.4.1 CONTINUOUS FOCUS OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ON TARGETED THERAPIES FOR PRECISION MEDICINE TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 86
10.5 OTHER END USERS 87
11 NGS SAMPLE PREPARATION MARKET, BY REGION 89
11.1 INTRODUCTION 90
11.2 NORTH AMERICA 91
11.3 US 96
11.3.1 FAVORABLE REGULATORY AND REIMBURSEMENT SCENARIO FOR NGS-BASED DIAGNOSTICS TESTS IN THE COUNTRY DRIVES THE MARKET 96
11.4 CANADA 99
11.4.1 FAVORABLE GOVERNMENT FUNDING SCENARIO IN CANADA BOOST GENOMICS RESEARCH 99
11.5 EUROPE 101
11.6 GERMANY 107
11.6.1 STRONG R&D BASE IN GERMANY SUPPORTS MARKET GROWTH 107
11.7 UK 109
11.7.1 USE OF NGS-BASED TEST FOR DISEASE DIAGNOSIS WILL DRIVE MARKET GROWTH 109
11.8 FRANCE 112
11.8.1 SUPPORT FOR GENOMICS RESEARCH IS A KEY DRIVER OF MARKET GROWTH 112
11.8.2 ROE 114
11.9 ASIA PACIFIC 116
11.9.1 CHINA 123
11.9.1.1 NGS players are focusing on strengthening their presence and offerings in the country 123
11.9.2 JAPAN 125
11.9.2.1 Growing genetic disorder incidence in Japan is driving market growth 125
11.9.3 INDIA 128
11.9.3.1 Awareness on NGS and its advantages is still growing in India 128
11.9.4 REST OF ASIA PACIFIC 130
11.10 REST OF THE WORLD 132
12 COMPETITIVE LANDSCAPE 138
12.1 OVERVIEW 138
12.2 MARKET SHARE ANALYSIS, 2018 139
12.3 COMPETITIVE SCENARIO 141
12.3.1 PRODUCT LAUNCHES 141
12.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 142
12.3.3 ACQUISITIONS 142
12.3.4 EXPANSIONS 143
12.3.5 OTHER DEVELOPMENTS 143
12.4 VENDOR INCLUSION CRITERIA 143
12.5 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET – 2017) 143
12.5.1 VISIONARY LEADERS 143
12.5.2 INNOVATORS 144
12.5.3 DYNAMIC DIFFERENTIATORS 144
12.5.4 EMERGING PLAYERS 144
13 COMPANY PROFILE 145
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 AGILENT TECHNOLOGIES, INC. 145
13.2 BECTON, DICKINSON AND COMPANY 152
13.3 BECKMAN COULTER (A SUBSIDIARY OF DANAHER) 154
13.4 F. HOFFMANN-LA ROCHE AG 157
13.5 ILLUMINA, INC. 161
13.6 NEW ENGLAND BIOLABS, INC. 165
13.7 NUGEN TECHNOLOGIES, INC. (PART OF TECAN TRADING AG) 170
13.8 OXFORD GENE TECHNOLOGY (PART OF SYSMEX) 173
13.9 OXFORD NANOPORE TECHNOLOGIES, LTD. 175
13.10 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 177
13.11 PERKINELMER, INC. 180
13.12 QIAGEN N.V. 182
13.13 RAINDANCE TECHNOLOGIES, INC. (PART OF BIO-RAD LABORATORIES) 186
13.14 SWIFT BIOSCIENCES INC. 188
13.15 THERMO FISHER SCIENTIFIC INC. 190
*Business Overview, Products Offered, Recent Developments,, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 194
14.1 DISCUSSION GUIDE 194
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 200
14.3 AVAILABLE CUSTOMIZATIONS 202
14.4 RELATED REPORTS 202
14.5 AUTHOR DETAILS 203

LIST OF TABLES

TABLE 1 NGS SAMPLE PREPARATION MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 47
TABLE 2 NGS SAMPLE PREPARATION REAGENTS AND CONSUMABLES MARKET,
BY REGION, 2017–2024 (USD MILLION) 48
TABLE 3 NGS SAMPLE PREPARATION WORKSTATIONS MARKET, BY REGION,
2017–2024 (USD MILLION) 49
TABLE 4 NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 51
TABLE 5 LIBRARY PREPARATION MARKET, BY TYPE, 2017–2024 (USD MILLION) 52
TABLE 6 LIBRARY PREPARATION MARKET, BY REGION, 2017–2024 (USD MILLION) 53
TABLE 7 DNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 53
TABLE 8 DNA LIBRARY PREPARATION MARKET, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 9 WHOLE EXOME SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION) 54
TABLE 10 TARGETED SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION) 55
TABLE 11 WHOLE GENOME SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION) 56
TABLE 12 OTHER DNA LIBRARY PREPARATION APPLICATIONS MARKET, BY REGION,
2017–2024 (USD MILLION) 57
TABLE 13 RNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 58
TABLE 14 RNA LIBRARY PREPARATION MARKET, BY REGION, 2017–2024 (USD MILLION) 58
TABLE 15 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 16 WHOLE TRANSCRIPTOME SEQUENCING MARKET, BY REGION,
2017–2024 (USD MILLION) 60
TABLE 17 OTHER RNA LIBRARY PREPARATION APPLICATIONS MARKET,
BY REGION, 2017–2024 (USD MILLION) 60
TABLE 18 TARGET ENRICHMENT MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 61
TABLE 19 TARGET ENRICHMENT MARKET, BY REGION, 2017–2024 (USD MILLION) 62
TABLE 20 TARGETED SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION) 62
TABLE 21 WHOLE EXOME SEQUENCING MARKET, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 22 OTHER TARGET ENRICHMENT APPLICATIONS MARKET, BY REGION,
2017–2024 (USD MILLION) 64
TABLE 23 QUALITY CONTROL MARKET, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 24 NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY 67
TABLE 25 NGS LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 67
TABLE 26 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET FOR SEQUENCING
BY SYNTHESIS, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 27 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2017–2024 (USD MILLION) 70
TABLE 28 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2017–2024 (USD MILLION) 71
TABLE 29 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET FOR NANOPORE SEQUENCING, BY REGION, 2017–2024 (USD MILLION) 72
TABLE 30 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2017–2024 (USD MILLION) 72
TABLE 31 NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 74
TABLE 32 NGS SAMPLE PREPARATION MARKET FOR DIAGNOSTICS, BY TYPE,
2017–2024 (USD MILLION) 75
TABLE 33 NGS SAMPLE PREPARATION MARKET FOR DIAGNOSTICS, BY REGION,
2017–2024 (USD MILLION) 76
TABLE 34 NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY REGION,
2017–2024 (USD MILLION) 80
TABLE 35 NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2017–2024 (USD MILLION) 81
TABLE 36 NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION) 82
TABLE 37 NGS SAMPLE PREPARATION MARKET, BY END USER, 2017–2024 (USD MILLION) 84
TABLE 38 NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2017–2024 (USD MILLION) 85
TABLE 39 NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017–2024 (USD MILLION) 86
TABLE 40 NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION) 87
TABLE 41 NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY REGION,
2017–2024 (USD MILLION) 88
TABLE 42 NGS SAMPLE PREPARATION MARKET, BY REGION, 2017–2024 (USD MILLION) 90
TABLE 43 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 92
TABLE 44 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 92
TABLE 45 NORTH AMERICA: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW, 2017–2024 (USD MILLION) 92
TABLE 46 NORTH AMERICA: LIBRARY PREPARATION MARKET, BY TYPE,
2017–2024 (USD MILLION) 93
TABLE 47 NORTH AMERICA: DNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 93
TABLE 48 NORTH AMERICA: RNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 94
TABLE 49 NORTH AMERICA: TARGET ENRICHMENT MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 94
TABLE 50 NORTH AMERICA: NGS LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 95
TABLE 51 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 95
TABLE 52 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 96
TABLE 53 US: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 97
TABLE 54 US: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 97
TABLE 55 US: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 98
TABLE 56 US: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 98
TABLE 57 CANADA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 99
TABLE 58 CANADA: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 99
TABLE 59 CANADA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 100
TABLE 60 CANADA: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 100
TABLE 61 EUROPE: NGS SAMPLE PREPARATION MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 102
TABLE 62 EUROPE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 102
TABLE 63 EUROPE: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 103
TABLE 64 EUROPE: LIBRARY PREPARATION MARKET, BY TYPE, 2017–2024 (USD MILLION) 103
TABLE 65 EUROPE: DNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 104
TABLE 66 EUROPE: RNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 104
TABLE 67 EUROPE: TARGET ENRICHMENT MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 105
TABLE 68 EUROPE: NGS LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION) 105
TABLE 69 EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 106
TABLE 70 EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 106
TABLE 71 GERMANY: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 107
TABLE 72 GERMANY: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 108
TABLE 73 GERMANY: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 108
TABLE 74 GERMANY: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 109
TABLE 75 UK: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 110
TABLE 76 UK: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 110
TABLE 77 UK: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 111
TABLE 78 UK: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 111
TABLE 79 FRANCE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 112
TABLE 80 FRANCE: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 112
TABLE 81 FRANCE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 113
TABLE 82 FRANCE: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 113
TABLE 83 ROE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 114
TABLE 84 ROE: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 115
TABLE 85 ROE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 115
TABLE 86 ROE: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 116
TABLE 87 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 118
TABLE 88 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 118
TABLE 89 ASIA PACIFIC: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW, 2017–2024 (USD MILLION) 119
TABLE 90 ASIA PACIFIC: LIBRARY PREPARATION MARKET, BY TYPE,
2017–2024 (USD MILLION) 119
TABLE 91 ASIA PACIFIC: DNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 120
TABLE 92 ASIA PACIFIC: RNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 120
TABLE 93 ASIA PACIFIC: TARGET ENRICHMENT MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 121
TABLE 94 ASIA PACIFIC: NGS LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 121
TABLE 95 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 122
TABLE 96 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 122
TABLE 97 CHINA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 123
TABLE 98 CHINA: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 124
TABLE 99 CHINA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 124
TABLE 100 CHINA: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 125
TABLE 101 JAPAN: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 126
TABLE 102 JAPAN: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 126
TABLE 103 JAPAN: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 127
TABLE 104 JAPAN: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 127
TABLE 105 INDIA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 128
TABLE 106 INDIA: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 129
TABLE 107 INDIA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 129
TABLE 108 INDIA: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 130
TABLE 109 ROAPAC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 130
TABLE 110 ROAPAC: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 131
TABLE 111 ROAPAC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 131
TABLE 112 ROAPAC: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 132
TABLE 113 ROW: NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 134
TABLE 114 ROW: NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2017–2024 (USD MILLION) 134
TABLE 115 ROW: LIBRARY PREPARATION MARKET, BY TYPE, 2017–2024 (USD MILLION) 134
TABLE 116 ROW: DNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 135
TABLE 117 ROW: RNA LIBRARY PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 135
TABLE 118 ROW: TARGET ENRICHMENT MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 136
TABLE 119 ROW: NGS LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET,
BY TECHNOLOGY, 2017–2024 (USD MILLION) 136
TABLE 120 ROW: NGS SAMPLE PREPARATION MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 137
TABLE 121 ROW: NGS SAMPLE PREPARATION MARKET, BY END USER,
2017–2024 (USD MILLION) 137


LIST OF FIGURES

FIGURE 1 NGS SAMPLE PREPARATION MARKET: RESEARCH METHODOLOGY STEPS 22
FIGURE 2 RESEARCH DESIGN 23
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 4 PRODUCT-BASED MARKET ESTIMATION: NGS SAMPLE PREPARATION MARKET 27
FIGURE 5 END USER-BASED MARKET ESTIMATION: NGS SAMPLE PREPARATION MARKET 28
FIGURE 6 NGS SAMPLE PREPARATION MARKET: DATA TRIANGULATION 29
FIGURE 7 NGS SAMPLE PREPARATION MARKET, BY PRODUCT,
2019 VS. 2024 (USD MILLION) 31
FIGURE 8 NGS REAGENTS AND CONSUMABLES MARKET, BY WORKFLOW,
2019–2024 (USD MILLION) 32
FIGURE 9 NGS SAMPLE PREPARATION MARKET SHARE, BY APPLICATION 2019 VS. 2024 32
FIGURE 10 NGS SAMPLE PREPARATION MARKET, BY END USER
2019 VS. 2024 (USD MILLION) 33
FIGURE 11 LIBRARY PREPARATION & TARGET ENRICHMENT MARKET, BY TECHNOLOGY 2019–2024 (USD MILLION) 34
FIGURE 12 ASIA PACIFIC WILL GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 35
FIGURE 13 DECLINING COST OF SEQUENCING IS THE KEY DRIVER FOR THE MARKET 36
FIGURE 14 REAGENTS AND CONSUMABLES SEGMENT HELD THE LARGEST
SHARE OF THE MARKET 37
FIGURE 15 ACADEMIC INSTITUTES AND RESEARCH CENTERS SEGMENT IS PROJECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 38
FIGURE 16 DIAGNOSTICS SEGMENT IS PROJECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 39
FIGURE 17 APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 40
FIGURE 18 NGS SAMPLE PREPARATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
FIGURE 19 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2017 43
FIGURE 20 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET SNAPSHOT 91
FIGURE 21 EUROPE: NGS SAMPLE PREPARATION MARKET SNAPSHOT 101
FIGURE 22 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET SNAPSHOT 117
FIGURE 23 ROW: NGS SAMPLE PREPARATION MARKET SNAPSHOT 133
FIGURE 24 KEY DEVELOPMENTS IN THE NGS SAMPLE PREPARATION MARKET BETWEEN 2016 AND 2019 138
FIGURE 25 NGS SAMPLE PREPARATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 139
FIGURE 26 NGS WORKSTATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 139
FIGURE 27 NGS LIBRARY PREPARATION & TARGET ENRICHMENTMARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 140
FIGURE 28 COMPETITIVE LEADERSHIP MAPPING: KEY GLOBAL PLAYERS 144
FIGURE 29 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2018) 145
FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018) 152
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2018) 154
FIGURE 32 ROCHE: COMPANY SNAPSHOT (2018) 157
FIGURE 33 ILLUMINA, INC: COMPANY SNAPSHOT (2018) 161
FIGURE 34 TECAN TRADING AG: COMPANY SNAPSHOT (2018) 170
FIGURE 35 SYSMEX CORPORATION: COMPANY SNAPSHOT (2018) 173
FIGURE 36 PACIFIC BIOSCIENCES OF CALIFORNIA: COMPANY SNAPSHOT (2017) 177
FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT (2018) 180
FIGURE 38 QIAGEN N.V.: COMPANY SNAPSHOT (2018) 182
FIGURE 39 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2018) 186
FIGURE 40 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2018) 190


★調査レポート[次世代シーケンシング(NGS)サンプル調製の世界市場予測(~2024年)] ( NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024 / BT 7081) 販売に関する免責事項
[次世代シーケンシング(NGS)サンプル調製の世界市場予測(~2024年)] ( NGS Sample Preparation Market by Product (Reagent, Workstations), Workflow (Library Preparation [DNA, RNA], Target Enrichment), Application (Infectious Disease, Cancer Diagnostics), Technology (SMRT, Nanopore) - Forecast to 2024 / BT 7081) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆